Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients

The Egyptian Journal of Otolaryngology

Table 8 Duration between covidCOVID-19 infection and start of mucormycosis

	Duration between COVID-19 infection and start of mucormycosis		Test value	p-value	Sig.
	Median (IQR)	Range	Test value	p-value	Sig.
Total no. of surgical procedures
1	27.5 (17–57.5)	14–90	0.078^b	0.962	NS
2	25.5 (21–60)	7–90
3	30 (30–30)	30–30
Septectomy
No	23 (14–60)	7–90	−0.995^a	0.320	NS
Yes	30 (25.5–60)	14–90	−0.995^a	0.320	NS
Palatal debrid
No	30 (20.5–52.5)	7–90	−0.632^a	0.527	NS
Yes	55.5 (21–90)	21–90	−0.632^a	0.527	NS
Sphenoidotomy
No	14 (10.5–22)	7–30	−2.355^a	0.019	S
Yes	35 (21–60)	14–90	−2.355^a	0.019	S
Death
No	30 (21–60)	7–90	−0.355^a	0.723	NS
Yes	30 (14–45)	14–80	−0.355^a	0.723	NS

P-value > 0.05, nonsignificant; P-value < 0.05, significant; P-value < 0.01, highly significant
^aMann-Whitney test
^bKruskal-Wallis test